Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications pulse wave velocity associated coronary calcification improves its prediction young
… gain the most useful insights about your product, its competitors, and the current and future landscape. We …
Health Economics: Database Studies Real world data—from administrative claims data, electronic medical records (EMRs), disease registries, and other health data sources—can help you better understand your market and how to position your product for …
Pharmacoepidemiology and Risk Management Regulatory Real-World Evidence Research Let us help you ensure the safety of your patients by examining and understanding disease indicators and using real-world evidence to support your development and …
European Association for the Study of Diabetes (EASD) 2023 59th Annual Meeting Share on: Monday, October 2 - Friday, October 6, 2023 Conference website Research coauthored by RTI Health Solution experts will be presented at EASD 2023. Clinical profile …
… Guidance Draft On August 31, 2020, the FDA released its draft guidance titled “Principles for Selecting, … Instruments for Use in Medical Device Evaluation.” While its title suggests that the draft guidance applies only to … review of clinical outcome assessments and states that its purpose is to supplement existing resources. Some of the …
… world, RTI Health Solutions is committed to building on its diverse foundation to maintain an all-inclusive …
… For the 6th straight year, Forbes has included RTI in its list of America’s Best Midsize Employers RTI is ranked …
… each rating. Assessments with ratings of B+ were typically associated with a substantial improvement in clinical …
… or MS, is a progressive, disabling neurological disease associated with a significant humanistic and economic burden. …
… cap on drug costs. The IRA was implemented in 2023, and its impacts are already being felt. Government negotiation of … and medical technologies. As the HTAR moves along in its development, directives regarding rare disease therapies … countries. The EU has proposed a sweeping revision of its pharmaceutical legislation — the largest change in 20 …